AV-TEMECULA-CT
Manufacturer adverse-event records for AV-TEMECULA-CT come from the U.S. Food & Drug Administration (FDA) MAUDE database via openFDA, refreshed March 2026 - see our methodology. Not medical advice.
FDA MAUDE device safety record · 2008–2019 · heavy-book · elevated Death-code · injury-heavy
Death-code intensity
AV-TEMECULA-CT carries an elevated Death-code share
Death-coded event_type rows are 2,495 of 77,603 (3.22% · elevated tercile among 434 manufacturers). Absolute volume is heavy-book.
What the Death-code reading shows for AV-TEMECULA-CT
The standout signal for AV-TEMECULA-CT is Death-code intensity: 3.22% of 77,603 reports (elevated tercile), while absolute volume is heavy-book.
As a heavy-book manufacturer, portfolio size and reporting obligations inflate absolute counts - pair AV-TEMECULA-CT with device-family pages before treating company totals as a safety verdict. Event_type Death and Injury are one code per report; Patient Outcomes below use a separate FDA population.
Reports span 20 device types, led in this extract by Injury at 48,755 (62.8% of event_type total). Peak single-year volume reaches 10,159 reports across 12 years. These are raw FDA submissions, not adjudicated findings. Snapshot . Verify current communications on the FDA MDR page.
Event Types
Patient Outcomes
FDA patient-outcome codes (separate from event_type). Percentages use this chart's row total.
Devices (20)
Yearly Trend
Read our methodology - how this data is sourced, computed, and verified.